Related Experiment Videos
Epithelial-myoepithelial carcinoma harboring p53 mutation
11st Department of Pathology, Oita Medical University, Japan. daatom@oita-med.ac.jp
Summary
This study reports the first known case of epithelial-myoepithelial carcinoma in the parotid gland with a p53 gene mutation. The mutation was identified in codon 207 of the p53 tumor-suppressor gene.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland neoplasm.
- Understanding the genetic alterations in EMC is crucial for diagnosis and treatment.
Observation:
- A case of parotid gland EMC in a 67-year-old female is presented.
- The tumor exhibited a biphasic cell population (epithelial and myoepithelial cells) with distinct immunophenotypes.
- Solid nests of epithelial cells showed increased proliferation marker (PCNA) expression.
Findings:
- Genetic analysis revealed a novel mutation in codon 207 of the p53 tumor-suppressor gene.
- This is the first documented instance of a p53 mutation in salivary gland EMC.
- The mutation involved an aspartic acid to glycine substitution.
Implications:
- The findings suggest a potential role for p53 mutations in the pathogenesis of EMC.
- This discovery may contribute to improved diagnostic markers and targeted therapies for EMC.
- Further research is warranted to explore the functional impact of this p53 mutation.